Temozolomide trials for Lung cancer

All Temozolomide trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Temozolomide for Lung cancer

• A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
  NCT07492680 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 57 locations
• Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
  NCT06931626 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
  NCT04919382 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations

Common questions

How many trials study Temozolomide for Lung cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.